Article Information
History
- August 21, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Marc C. Shamier1,
- Alma Tostmann2,
- Susanne Bogers1,
- Janet de Wilde1,
- Jeroen IJpelaar1,
- Willemijn A. van der Kleij3,
- Herbert de Jager3,
- Bart L. Haagmans1,
- Richard Molenkamp1,
- Bas. B. Oude Munnink1,
- Carsten van Rossum2,
- Janette Rahamat-Langendoen2,
- Nannet van der Geest5,
- Chantal P. Bleeker-Rovers4,
- Heiman Wertheim2,
- Marion P.G. Koopmans1 and
- Corine H. GeurtsvanKessel1,*
- 1Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands
- 2Department of Medical Microbiology, Radboud Centre for Infectious Diseases, Radboud university medical center, Nijmegen, The Netherlands
- 3Department of Occupational Health Services, Erasmus Medical Center, Rotterdam, Netherlands
- 4Department of Internal Medicine, Radboud Centre for Infectious Diseases, Radboud university medical center, Nijmegen, The Netherlands
- 5Department of Occupational Health, Radboud university medical center, Nijmegen, The Netherlands
- ↵*Corresponding authors: email c.geurtsvankessel{at}erasmusmc.nl
Posted August 21, 2021.
Virological characteristics of SARS-CoV-2 vaccine breakthrough infections in health care workers
